Abstract

Several neurodegenerative disorders are characterized by protein misfolding, a phenomenon that results in perturbation of cellular homeostasis. We recently identified the protective activity of the ER stress response factor XBP1 (X-box binding protein 1) against Amyloid-ß1-42 (Aß42) neurotoxicity in cellular and Drosophila models of Alzheimer’s disease. Additionally, subtoxic concentrations of Aß42 soluble aggregates (oligomers) induced accumulation of spliced (active) XBP1 transcripts, supporting the involvement of the ER stress response in Aß42 neurotoxicity. Here, we tested the ability of three additional disease-related amyloidogenic proteins to induce ER stress by analyzing XBP1 activation at the RNA level. Treatment of human SY5Y neuroblastoma cells with homogeneous preparations of α-Synuclein (α-Syn), Prion protein (PrP106–126), and British dementia amyloid peptide (ABri1-34) confirmed the high toxicity of oligomers compared to monomers and fibers. Additionally, α-Syn oligomers, but not monomers or fibers, demonstrated potent induction of XBP1 splicing. On the other hand, PrP106–126 and ABri1-34 did not activate XBP1. These results illustrate the biological complexity of these structurally related assemblies and argue that oligomer toxicity depends on the activation of amyloid-specific cellular responses.

Highlights

  • We are interested in understanding the role of the unfolded protein response (UPR) in disease because several recent studies have linked ER stress to some of the most prevalent neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS) [28]

  • XBP1 has only recently been used as a UPR marker based on the diagnostic value of the small intron regulated by the IRE1 sensor

  • We showed that transgenic flies expressing human Aß42 and rat PC12 cells treated with Aß42 oligomers induce unconventional splicing of XBP1 [6]

Read more

Summary

Objectives

The purpose of the present study was threefold: (1) To develop a sensitive assay to detect XBP1 activation at the RNA level, (2) compare the ability of several amyloidogenic proteins to induce XBP1 splicing in the same experimental conditions, an (3) determine which assemblies are responsible for this activity

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call